[Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].

AIM To study hypotensive effectiveness and organ-protective properties of telmisartan in patients with essential hypertension (EH). MATERIAL AND METHODS The trial enrolled 33 patients with EH of stage II, blood pressure (BP) elevation of the first and second degree, with ultrasound-diagnosed left ventricular (LV) hypertrophy and/or increased thickness of… CONTINUE READING